In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (flobetapir F 18)
An 18F-labeled PET amyloid-β (Aβ) imaging agent could facilitate the clinical evaluation of
late-life cognitive impairment by providing an objective measure for Alzheimer disease (AD) …
late-life cognitive impairment by providing an objective measure for Alzheimer disease (AD) …
[PDF][PDF] In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)
DF Wong, PB Rosenberg, Y Zhou, A Kumar… - J Nucl …, 2010 - researchgate.net
An 18F-labeled PET amyloid-b (Ab) imaging agent could facilitate the clinical evaluation of
late-life cognitive impairment by providing an objective measure for Alzheimer disease (AD) …
late-life cognitive impairment by providing an objective measure for Alzheimer disease (AD) …
In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand F-18-AV-45 (Flobetapir F 18)
DF Wong, W Ye, J Hilton, C Lyketsos… - Journal of Nuclear …, 2010 - hero.epa.gov
An F-18-labeled PET amyloid-beta (A beta) imaging agent could facilitate the clinical
evaluation of late-life cognitive impairment by providing an objective measure for Alzheimer …
evaluation of late-life cognitive impairment by providing an objective measure for Alzheimer …
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (flobetapir F 18)
DF Wong, PB Rosenberg, Y Zhou… - Journal of Nuclear …, 2010 - pure.johnshopkins.edu
An 18 F-labeled PET amyloid-β (Aβ) imaging agent could facilitate the clinical evaluation of
late-life cognitive impairment by providing an objective measure for Alzheimer disease (AD) …
late-life cognitive impairment by providing an objective measure for Alzheimer disease (AD) …
[PDF][PDF] In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)
DF Wong, PB Rosenberg, Y Zhou, A Kumar… - J Nucl …, 2010 - Soc Nuclear Med
An 18F-labeled PET amyloid-b (Ab) imaging agent could facilitate the clinical evaluation of
late-life cognitive impairment by providing an objective measure for Alzheimer disease (AD) …
late-life cognitive impairment by providing an objective measure for Alzheimer disease (AD) …
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (flobetapir F 18)
DF Wong, PB Rosenberg, Y Zhou… - Journal of Nuclear …, 2010 - research.ed.ac.uk
An 18 F-labeled PET amyloid-β (Aβ) imaging agent could facilitate the clinical evaluation of
late-life cognitive impairment by providing an objective measure for Alzheimer disease (AD) …
late-life cognitive impairment by providing an objective measure for Alzheimer disease (AD) …
[HTML][HTML] In Vivo Imaging of Amyloid Deposition in Alzheimer's Disease using the Novel Radioligand [18F] AV-45 (Florbetapir F 18)
DF Wong, PB Rosenberg, Y Zhou… - Journal of nuclear …, 2010 - ncbi.nlm.nih.gov
Methods An open-label, multicenter, brain imaging, metabolism and safety study of [18 F] AV-
45 was performed on 16 patients with Alzheimer's disease (AD: MMSE 19.3+/− 3.1; Age …
45 was performed on 16 patients with Alzheimer's disease (AD: MMSE 19.3+/− 3.1; Age …
[PDF][PDF] In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)
DF Wong, PB Rosenberg, Y Zhou, A Kumar… - J Nucl Med, 2010 - Citeseer
An 18F-labeled PET amyloid-b (Ab) imaging agent could facilitate the clinical evaluation of
late-life cognitive impairment by providing an objective measure for Alzheimer disease (AD) …
late-life cognitive impairment by providing an objective measure for Alzheimer disease (AD) …
[PDF][PDF] In Vivo Imaging of Amyloid Deposition in Alzheimer's Disease using the Novel Radioligand [18F] AV-45 (Florbetapir F 18)
DF Wongx, PB Rosenberg, Y Zhoux, A Kumarx… - J Nucl Med, 2010 - academia.edu
Abstract Introduction—An [18F] labeled PET amyloid (Aβ) imaging agent could facilitate
clinical evaluation of late-life cognitive impairment by providing an objective measure for …
clinical evaluation of late-life cognitive impairment by providing an objective measure for …
In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand^ sup 18^ F-AV-45 (Flobetapir F 18)
DF Wong, PB Rosenberg, Y Zhou… - The Journal of …, 2010 - search.proquest.com
Abstract An^ sup 18^ F-labeled PET amyloid-β (Aβ) imaging agent could facilitate the
clinical evaluation of late-life cognitive impairment by providing an objective measure for …
clinical evaluation of late-life cognitive impairment by providing an objective measure for …